Glaxosmithkline Phar - Quarterly Results
29th Oct 2021

The company witnessed a 12.75% growth in the revenue at Rs. 9915.30 millions for the quarter ended September 2021 as compared to Rs. 8793.90 millions during the year-ago period.The Net Profit of the company reported a remarkable increase of 164.90% to Rs. 2026.50  millions  from Rs. 765.00 millions in previous same quarter.The company reported a good operating profit of 2894.40 millions compared to 2139.40 millions of corresponding previous quarter.



(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 9915.30 8793.90 12.75 17649.90 15280.40 15.51 31937.30 32246.80 -0.96
Other Income 150.50 89.20 68.72 467.80 667.10 -29.88 1101.90 775.60 42.07
PBIDT 2894.40 2139.40 35.29 4718.60 3860.80 22.22 8051.40 7360.10 9.39
Interest 3.50 8.80 -60.23 11.40 19.60 -41.84 35.30 63.40 -44.32
PBDT 2890.90 1489.30 94.11 4707.20 3199.90 47.10 6290.10 4051.80 55.24
Depreciation 176.00 219.60 -19.85 353.10 437.30 -19.25 792.80 826.80 -4.11
PBT 2714.90 1269.70 113.82 4354.10 2762.60 57.61 5497.30 3225.00 70.46
TAX 688.40 504.70 36.40 1123.60 888.00 26.53 1921.70 2124.50 -9.55
Deferred Tax -37.80 28.60 -232.17 -72.60 30.80 -335.71 78.70 -477.20 -116.49
PAT 2026.50 765.00 164.90 3230.50 1874.60 72.33 3575.60 1100.50 224.91
Equity 1694.10 1694.10 0.00 1694.10 1694.10 0.00 1694.10 1694.10 0.00
PBIDTM(%) 29.19 24.33 19.99 26.73 25.27 5.81 25.21 22.82 10.45